Study of childhood primary sclerosing cholangitis types
Part of Digestive system clinical trials.
This study follows children and young adults with primary sclerosing cholangitis (PSC) to understand the condition and how it shows up on scans or biopsy. It may help doctors better recognize PSC and choose the best next steps for care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 2 and 25 years old (or 8 to 25 for the scan part)
- Have a doctor diagnosis of PSC affecting the bile ducts (large duct) confirmed by scan images
- Or have PSC affecting smaller bile ducts (small duct) confirmed by a past liver biopsy review
- Be willing and able to follow the study plan for the full study time
- Be able to agree to the study (consent/assent) and have a guardian’s consent if needed
- For MRI/scan participants: have no MRI safety problems and no skin issue that could worsen with scanning treatment/gel
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what drives primary sclerosing cholangitis (PSC) and how it affects the body, using a team approach and medical tests like scans and blood work. It may help researchers understand PSC better and could improve future treatment decisions.
This study collects bile and uses it to grow small lab models (organoids) from people with primary sclerosing cholangitis (PSC) and from people without PSC. Researchers want to better understand how PSC changes bile cells, which could improve future diagnosis or treatments.
This study collects and stores samples from people with PSC (primary sclerosing cholangitis), PBC (primary biliary cholangitis), and some related liver conditions. Researchers use these samples to better understand these diseases and support future research.
This study follows people diagnosed with primary sclerosing cholangitis to better understand the condition over time. It may help doctors learn which factors affect health and care, and improve future treatment decisions.
This study creates a national database for people diagnosed with primary sclerosing cholangitis (PSC). It may help researchers learn more about the condition by collecting health information from participants.
This study checks whether annual liver scans using MRI (including a special MRI procedure and possibly contrast dye) can help people with primary sclerosing cholangitis. It may improve how the condition is monitored over time.
Hear when a new Primary Sclerosing Cholangitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.